Delivery Order SPE2DB20D1100-SPE2DB25FE2L1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity, with a ceiling value of $2,116.72. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,138.04 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,044.28 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Briviact 100 mg tablets (60-count packages) with a ceiling value of $1,067.55. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $19,116.30 to AmerisourceBergen Drug Corp for the supply of Briviact 10 mg/mL oral solution in 300 mL quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 6, 2025, and was awarded on August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Briviact 100 mg tablets (60-count packaging). This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,706.39 and an ultimate completion date of August 15, 2025. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $2,839.50 delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $5,833.23 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE2L1Delivery Order
The Defense Logistics Agency awarded a $7,234.61 delivery order to AmerisourceBergen Drug Corp for Briviact 10 mg/ml oral solution (300ml) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive pharmaceutical supply agreement with DLA. The company's DLA contract vehicle enables it to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. This delivery order for Briviact, an antiretroviral medication, exemplifies the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 8/22/25 |